Old Web
English
Sign In
Acemap
>
authorDetail
>
Larissa Bittencourt da Silva
Larissa Bittencourt da Silva
Novartis
Rituximab
Oncology
Pathology
Medicine
Diffuse large B-cell lymphoma
2
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
REFLECT real-world evidence (RWE) prospective study update: Efficacy and safety results of Sandoz biosimilar rituximab (SDZ-RTX) for the treatment of diffuse large B-cell lymphoma (DLBCL).
2020
Journal of Clinical Oncology
Manfred Welslau
Norbert Marschner
Burkhard Otremba
Julian Topaly
Larissa Bittencourt da Silva
Show All
Source
Cite
Save
Citations (1)
Sandoz rituximab (GP2013; SDZ-RTX) for the treatment of diffuse large B-cell lymphoma (DLBCL): Interim safety results of the non-interventional, observational, multicenter, open-label REFLECT study.
2019
Journal of Clinical Oncology
Manfred Welslau
Norbert Marschner
Thomas Wolff
Burkhard Otremba
Julian Topaly
Larissa Bittencourt da Silva
Show All
Source
Cite
Save
Citations (1)
1